Beta blockers as cardioprotective agents: Part I--Insights into mechanisms of action.
Frishman
Willima H
WH
Department of Medicine, New York Medical College and the Westchester Medical Center, Valhalla, USA.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000503:physiopathology; D002316:Cardiotonic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D013564:Sympathetic Nervous System / Q000503:physiopathology; D014481:United States
D000319:Adrenergic beta-Antagonists; D002316:Cardiotonic Agents